Syndax Pharmaceuticals

SNDX

NASDAQHealth Care

Income Statement

Total Revenue$23.68M

Gross Profit$22.85M

Operating Income$-339.67M

EBITDA$-312.83M

EBIT$-313.83M

Pre-tax Income$-243.25M

Net Income$-318.76M

Cash Equivalent$127M

Total Debt$87.28M

Book Value$395.2M

Book Value Per Share4.64

Return on Equity (ROE)-110.63%

Return on Assets (ROA)-43.98%

Return on Invested Capital (ROI)-50.45%

Net Profit Margin-1346.11%

Current Ratio5.82

Quick Ratio5.77

Long-Term Debt / Equity1.15